SMI
11.791,91
PKT
-135,20
PKT
-1,13
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
08.04.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
08.04.20 | Givaudan Underperform | Bernstein Research | |
08.04.20 | Nestlé Hold | HSBC | |
08.04.20 | Holcim kaufen | JP Morgan Chase & Co. | |
07.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
07.04.20 | Givaudan Underweight | Barclays Capital | |
07.04.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
07.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
07.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
07.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
07.04.20 | Holcim buy | Goldman Sachs Group Inc. | |
06.04.20 | Givaudan add | Baader Bank | |
06.04.20 | Novartis Hold | Deutsche Bank AG | |
06.04.20 | Roche buy | Deutsche Bank AG | |
06.04.20 | Nestlé overweight | JP Morgan Chase & Co. | |
03.04.20 | Swiss Re Sector Perform | RBC Capital Markets | |
03.04.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
03.04.20 | Roche overweight | Barclays Capital | |
03.04.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
02.04.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
02.04.20 | Swiss Re Sector Perform | RBC Capital Markets | |
02.04.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
02.04.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
02.04.20 | Zurich Insurance overweight | Barclays Capital | |
02.04.20 | Swiss Re overweight | Barclays Capital | |
02.04.20 | Nestlé buy | Goldman Sachs Group Inc. | |
02.04.20 | UBS overweight | JP Morgan Chase & Co. | |
02.04.20 | UBS Neutral | JP Morgan Chase & Co. | |
01.04.20 | Roche overweight | JP Morgan Chase & Co. | |
01.04.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
01.04.20 | Novartis buy | Jefferies & Company Inc. | |
31.03.20 | ABB (Asea Brown Boveri) Hold | Kepler Cheuvreux | |
31.03.20 | UBS buy | Deutsche Bank AG | |
31.03.20 | UBS Hold | Deutsche Bank AG | |
31.03.20 | Novartis buy | Oddo BHF | |
31.03.20 | Roche buy | Oddo BHF | |
31.03.20 | UBS buy | Goldman Sachs Group Inc. | |
31.03.20 | UBS buy | Goldman Sachs Group Inc. | |
31.03.20 | Swiss Re buy | UBS AG | |
30.03.20 | UBS Verkaufen | DZ BANK |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.